About 12 results found for searched term "62-13-5" (0.055 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2370 | Adrenalone hydrochloride | Adrenergic Receptor |
| Adrenalone is an adrenergic agonist used as a topical vasoconstrictor and hemostatic, mainly acts on alpha-1 adrenergic receptors. | ||
| M3782 | Oxiracetam | 5-HT Receptor |
| ISF 2522 | ||
| Oxiracetam could decrease neural injury and increase ability of learning, memory and space cognition in traumatic brain injury rats. | ||
| M7119 | PF 06281355 | Others |
| PF-1355 | ||
| PF 06281355 is a selective myeloperoxidase (MPO) inhibitor. | ||
| M9522 | SRI-011381 | TGF-beta/Smad |
| SRI-011381 is an agonist of the TGF-beta signaling pathway for treatment of Alzheimer's disease. | ||
| M17113 | Heteropeucenin 7-methyl ether | Phenols |
| Heteropeucenin 7-methyl ether | ||
| M20321 | WAY-625135 | Casein Kinase |
| WAY-625135 is a Casein kinase 1δ inhibitor. | ||
| M25528 | (D) PPA-1 TFA | PD-1/PD-L1 |
| (D) PPA-1 TFA is the first hydrolysisresistant D-peptide antagonists to target the PD-1/PD-L1 pathway. (D) PPA-1 could bind PD-L1 at an affinity of 0.51 μM in vitro. | ||
| M28707 | VPC-14449 | Androgen Receptor |
| VPC-14449 is a potent and selective inhibitor of the DNA-binding domain of the androgen receptor (AR-DBD), with IC50 of 0.34 μM for full-length human AR. VPC-14449 reduces the ability of full-length AR as well as AR variants to interact with chromatin. VPC-14449 can be used for the research of prostate cancer. | ||
| M28716 | ML380 | AChR/AChE |
| ML380 is a potent, subtype-selective, and brain-penetrant positive allosteric modulator (PAM) of M5 mAChR, with EC50s of 190 and 610 nM for human and rat M5, respectively. ML380 exhibits moderate selectivity versus the M1 and M3 mAChR subtypes. ML380 could increase the affinity of ACh for the M5 mAChR. | ||
| M29734 | PW0787 | GPR/FFAR |
| PW0787 is a potent, selective, orally active, and brain-penetrant GPR52 agonist (EC50=135 nM). PW0787 suppresses psychostimulant behavior. | ||
| M29737 | dTAGV-1 TFA | PROTAC |
| dTAGV-1 TFA is a potent and selective degrader of mutant FKBP12F36V fusion proteins. dTAGV-1 TFA can induce degradation of FKBP12F36V-Nluc in vivo. | ||
| M52841 | (D)-PPA 1 | PD-1/PD-L1 |
| (D)-PPA 1 is a hydrolysisresistant d-peptide antagonist. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
